Increased α2AP expression may induce plasmin inhibition, impair fibrinolysis and proinflammatory cytokine production, and contribute to immune deposition, inflammatory responses, hypercoagulability, and thrombosis. The gene discussed is PLG; the disease is deep vein thrombosis.